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Abstract 
Evidence of Olfactory Deficits in Isolated Orofacial Clefting 
Sindhu Gopalaswamy B.D.S 
 
University of Pittsburgh, 2019 
 
 
ABSTRACT 
 
Orofacial clefting is one of the most common congenital malformations with a high 
morbidity and mortality rates. Clefts have a complex etiology and a wide range of phenotypic 
expression and subclinical features associated with it. Subclinical features occur at a higher rate in 
the unaffected first-degree relatives of the affected cleft patients compared to the normal 
population. Few examples of subclinical features include orbicularis oris muscle defects, facial 
dysmorphology, dermatoglyphic patterns. These subclinical features may represent an incomplete 
phenotypic expression. Identification of such traits in the families can help in understanding the 
genetic etiology. Reduced olfaction has been seen in patients affected with orofacial clefting and 
their unaffected relatives. However, it is not known whether these deficits were present in affected 
subjects and their families with different cleft types. 
The aim of this study is to investigate the prevalence of olfactory deficits in cases with 
different types of orofacial clefting (Cleft lip CL, cleft of the lip with or without palatal 
involvement CL/P, and cleft palate CP) and their unaffected first-degree relatives. 
The University of Pennsylvania Smell identification test (UPSIT) was administered to 32 
cases and 100 unaffected relatives. 447 people served as controls who had no history of orofacial 
clefting. The data was obtained from the larger Pittsburgh Orofacial Cleft Cohort. Only White, 
Non-Hispanic and subjects between the ages 10 and 59 years were included in the study. Exclusion 
criteria was based on nasal congestion, loss of smell due to trauma, depression (major and current 
depression), anti-depressants (Rolipram, Clomipramine, and Citalopram).  
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Chi-square test and Fishers exact test was used for categorical outcomes. Non parametric 
tests such as Shapiro Wilk and Mann Whitney test were used for quantitative scores. These tests 
were used to compare olfactory performance across groups.  
There is a significant difference in the olfactory deficits between the cases and controls (p-
value: 0.00004). There is a significant different in the different types of cleft among the cases (p- 
value: 0.0002 for CL, 4.41E-07 for CL/P, 0.002 for CP). There is a prevalence of olfactory deficits 
among the unaffected relatives belonging to the CL/P family type (p-value 0.03). 
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1.0 Introduction 
Orofacial clefting is one of the most common congenital conditions with high morbidity 
and mortality rates. It can be defined as the improper fusion of the orofacial structures and presents 
as cleft of the lip (CL), cleft of the palate (CP) or cleft involving both the lip and palate (CLP) 
(Keteyian and Mishina 2017). The prevalence of orofacial clefts (OFC) is 1 in 940 live births in 
the United States, making it the second most common congenital defect (Parker et al 2010).  
1.1 Epidemiology 
The worldwide prevalence rate of Orofacial clefts is 1 in 700 live births (World Health 
Organization [WHO], 2001). The prevalence of Orofacial clefts varies according to the population. 
The Asian and American Indian populations have the highest prevalence rate at 1 in 500 live births. 
African population have the lowest prevalence rate at 1 in 2500 live births (Dixon et al 2011). 
Differences also exist in regard to sex and laterality. CP is about twice as common in females, 
while the opposite is true for CL/P (Dixon et al., 2011; Mossey et al., 2009). Left sided unilateral 
CL cases are more common than right sided CL cases. (Dixon et al 2011). 
About 30% of the cleft cases are syndromic; i.e., syndromes that have cleft of the lip with 
or without palatal involvement (CL/P) or CP as one of the features, among other symptoms. 70% 
of the cases are non-syndromic and are thus isolated orofacial clefts. 50% of the patients with CP 
are thought to be syndromic, while only 5-10% of the CL/P cases are associated with a syndrome 
((World Health Organization [WHO], 2001). 
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1.2 Embryology 
The study of embryology has not only helped us in understanding the normal embryonic 
development of structures but has also helped us in tracing the pathogenesis defects associated 
with structures (Carlson, 2009). 
The embryological development of the face is quite complex. The major events in the 
formation of the face take place between the 4th and 8th weeks of development. The neural crest 
mesenchyme and the head ectoderm contribute to the formation of face and oral cavity (Som and 
Naidich, 2013). Five facial process/prominences make up the face: the frontonasal process (FNP), 
paired maxillary processes (MXP), and paired mandibular processes (MP). 
The FNP emerges in the later part of third week. The forebrain enlarges and pushes the 
ectoderm overlying it forward resulting in FNP formation. The stomodeum or the primitive mouth 
form during the beginning of 4th week below the developing forebrain and FNP. Lateral to the 
stomodeum is the MXP and caudally is the MP (Fig 2), which both derive from the first pharyngeal 
arch. The orbital floor, upper lip, inferior portion of lateral nasal wall are all formed from MXP. 
The MP eventually forms the lower jaw.  
 
1.2.1  Midface and Primary palate formation 
Around the end of the 4th week a pair of ectodermal thickenings called nasal placodes 
appear on the FNP. The mesenchyme that is present medially and laterally to each nasal placode 
form the medial nasal processes (MNP) and lateral nasal processes (LNP), respectively. The nasal 
groove is formed when the nasal placodes go below the surface and the groove gets deepened 
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further as the LNP and MNP develops. The deepening of nasal grooves leads to nasal pit formation 
(Fig 3). The pits continue into stomodeum to form nasal sacs. By the beginning of the 5th week the 
olfactory epithelium is formed due to the thickening of the ectoderm in the upper one third of the 
nasal sac. By the end of the fifth week there is vascular and sensory innervation formed between 
the nasal sac and the olfactory bulb.   
During the fifth week the MNP from each side fuses to form the intermaxillary segment 
(Fig 4). The intermaxillary segment forms the philtrum, premaxilla and the middle portion of the 
upper lip and jaw (Fig 5). The MXP first fuses with the LNP and then the MNP resulting in upper 
lip formation. The lateral part of the upper lip is formed by MXP. The cheek is formed when the 
lateral parts of MXP and MP fuse. (Warbrick, 1960; Tepper and Warren 2010; Mitchell et al, 
2010). 
The maxillary, medial and lateral nasal process forms the lip. A summary of lip 
development is given below (fig 1). 
 
Figure 1 Summary of Lip formation 
4th to 5th week- Frontonasal 
prominence widens.
Telencephalic vesicles are formed 
from forebrain.
Lower lip and jaw is formed.
4th week- 32 days- nasal placode 
is formed due to thickening of 
surface ectoderm.
Nasal pits are formed.
4th week- 35 days- Nasal pits are 
moved medially. Upper lip is 
formed by the fusion of medial 
and lateral nasal processes with 
the maxillary process below the 
lateral nasal process
5th week- 38 days- The maxillary 
and medial nasal process grow 
and push the lateral nasal process 
rostrally.
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Figure 2 Development of face 4th week  
Ref: Facial Embryology Honrado et al., (2018) 
  
 
                       
Figure 3 Development of face: End of 4th week.  
Ref: Human Embryology and Developmental Biology Carlson et al.,(2019) 
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Figure 4 Development of face: 5th week  
Ref: Embryology- Development of the Head and neck, the eye and ear Mitchell et al., (2009) 
 
                     
Figure 5 Development of face  
Ref: Embryology- Development of the Head and neck, the eye and ear Mitchell et al .,(2009) 
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1.2.2  Secondary palate formation: 
The secondary palate is formed by fusion of the lateral palatine processes, which derives 
from the MXP. Membranous bone is formed in the pre-maxilla and extends to the lateral palatine 
process, thus forming the hard palate. The posterior portions of lateral palatine process do not get 
ossified and forms the soft palate (Pansky, 1982). A summary of the formation of palate is given 
below (Som and Naidich, 2014). (Fig 6 and fig 7). 
 
Figure 6 Summary of palate formation 
 
 
6thweek-Two medial 
nasal processes fuse to 
form the Intermaxillary 
process 
Mesenchymal mass in 
the posterior part of 
intermaxillary process 
forms the primary 
palate. 
Later part of 6th week-
Formation of Lateral 
palatine processes-
Initially they grow 
between the developing 
tongue and alveolous. 
Later on the tongue moves 
downward away from the 
processes
7th- 8th weeks- Elevation 
of Palatal shelves
9th week- Anterior 
Palatal shelf fusion
12thweek- Posterior 
palatal shelf fusion.
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Figure 7 Development of palate  
Ref: Human Embryology and Developmental Biology Carlson et al.,(2019) 
 
 
1.3 Orofacial Clefting 
The formation of face is complex and there are many ways this highly regulated process 
could go wrong. Failure of fusion of any of the processes mentioned above may result in OFC. 
Failure of fusion of the MNP with MXP results in CL/P. CL/P can be unilateral or bilateral. Failure 
of fusion of the MNP results in median cleft (Koh et al, 2016). Failure of fusion of lateral parts of 
MXP and MP results in lateral cleft. Median and lateral clefts are rare. CP results when the two 
lateral palatine processes fail to fuse (Pansky, 1982). 
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Failure of the facial prominences to fuse can be due to genetic causes and/or environmental 
factors. 
 More than 400 syndromes have been found to be associated with CL/P, about 75% have a 
known genetic cause (Leslie and Marazita, 2013). In most of the cases the syndromes are inherited 
in a Mendelian manner. Van der Woude syndrome (VWS) (OMIM #: 119300) is the most common 
form of syndromic CL/P. Back in the 1950s, Van der Woude reported an autosomal dominant 
condition that was characterized by lower lip pits and CL/P or CP (Van Der Woude, 1954). Kondo 
et al (2002) carried out direct sequence analysis in the 350-kb critical region of VWS and identified 
mutations in the IRF6. When studying a pair of monozygotic twins, they had identified a nonsense 
mutation in the exon 4 of IRF6 region of the affected twin. 
70% of OFC do not occur with other abnormalities and are classified as non-syndromic. 
Mapping these complex traits are difficult since the affected family members don’t necessarily 
share a single genetic variant. Several approaches have been applied to identify the genetic causes 
of non-syndromic clefting 
1. Genetic Linkage Analysis: It is one of the commonly used method to map a 
chromosomal location to a diseased gene (Pulst; Cantor). In genetics the likelihood 
of two genes or a gene and a diseased gene to be located near each other and thus 
be inherited together is given by the LOD (Logarithm of Odds score). If everyone 
in the family has the same mutation, then the LOD score can be summed across the 
families thus increasing the power of linkage analysis. But in complex traits the 
affected members of the family have different mutations and summation of LOD 
score gives a negative result. Some family members don’t express the trait but will 
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still carry a mutation due to decreased penetrance. This breaks the linkage between 
the gene and the trait (Lidral et al, 2008). 
2. GWAS: This method tests millions of SNPs spread across the entire genome for 
association with a trait (Norrgard, 2008). Unlike the candidate gene approach, 
GWAS is agnostic. Because of the high number of SNPs tested, the threshold for 
statistical significance is very high. GWAS has now identified dozens of variants 
associated with non-syndromic OFC (Birnbaum et al., 2009; Beaty et al., 2010; 
Mangold et al., 2010). A GWAS can identify variants that may be a risk factor for 
the disease, but it does not necessarily identify the causal variant. Additional 
experimental testing is often needed to confirm a variant’s role in the pathogenesis 
of a disease or trait. 
3. Candidate Gene studies: Candidate genes can be selected based on animal studies 
and Mendelian clefting syndromes.  
i) Animal studies: Transgenic mouse models or mouse with spontaneous 
clefts are used to study candidate genes causing clefts. These are excellent 
models to study clefting as there are craniofacial developmental similarities 
between the humans and mouse models. Cleft palate phenotype in the 
mouse is more common than cleft lip phenotype (Schutte and Murray, 1999; 
Jugessar and Murray, 2005). 
ii) Mendelian forms of cleft: Sometimes Syndromic clefting which has a 
mendelian form of inheritance gives clues to isolated forms of clefting. 
VWS has a similar phenotype to isolated clefting. Mutations in IRF6 has 
been implicated in both VWS and isolated clefting (Zucherro et al., 2004) 
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A few of the major genes that have been implicated in isolated OFC include: 
1. IRF6: It was found that when disequilibrium testing that was carried at V274I 
position, there was an overtransmission of valine allele. A SNP of IRF6 results in 
this transmission. It was concluded that variation in IRF6 results in 12% of the CL/P 
(Zucherro et al., 2004). 
2. MSX1: It is a non-clustered homeobox gene that is a strong candidate gene in both 
syndromic and isolated forms of clefting due to the results of animal studies and 
linkage studies. It is strongly associated with tooth agenesis (Modesto, Krahn, 
Lidral et al., 2006) 
3. Fgfr: Rice et al (2004) studied that early palate formation is due to epithelial       
mesenchymal interactions. He studied the role of Fgf10, Fgfr2b and Shh signaling 
in the palate development. They had observed that mice which did not have Fgf10 
and its receptor Fgfr2b developed cleft palate. The differentiation process and the 
cell turnover rate was affected in these mice. Fgf10 signaling is in the palatal 
mesenchyme and Shh is in the epithelium. Fgf10 regulates the expression of Shh 
and the Fgf10 and Fgfr2b deficient mouse was shown to downregulate the 
expression of Shh (Murray and Schutte, 2004). 
Apart from genetics, environmental factors also play a significant role in OFC. 
Cigarette smoking has an effect on orofacial clefting. Development of CL/P and 
CPO has been associated with maternal cigarette smoking (Beaty et al., 1997) 
(Chung et al., 2000). Romitti et al (2007) reported that there was an association 
between alcohol intake and orofacial clefts. This association was influenced by the 
type of alcohol and folic acid intake. Folic acid deficiency has been shown to cause 
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facial clefts in rodents (Munger 2002) but the results are inconsistent in human 
(Gildestad et al., 2015; Shaw et al., 1995). 
1.4 Subclinical phenotypes in OFC 
In most genetic studies, OFC has been conceptualized as a simple binary trait – affected or 
unaffected. However, there is a wide range of phenotypic expression in OFC, including certain 
subclinical manifestations, which may be present at a higher than normal frequency in non-cleft 
relatives within affected families (Weinberg et al., 2006). Some of the subclinical phenotypes that 
have been documented in OFC include increase fluctuating asymmetry ( Neiswanger et al., 2005), 
increased non-right-handedness (Scott et al., 2004), altered dermatoglyphic patterns (Neiswanger 
et al., 2002; Scott et al., 2005), subtle changes in craniofacial morphology (Raghavan et al.,1994; 
Perkiomaki et al., 2003), increased frequency of orbicularis oris muscle defects (Neiswanger et 
al.,2001), and minor dental defects (Eerens et al., 2001).  The presence of these features is 
hypothesized to reflect underlying genetic risk factors for OFC. Thus, expanding the definition of 
OFC to include these subclinical expressions may aid in gene mapping efforts. 
 
1.5 Olfactory deficits as a subclinical phenotype in OFC 
               About 10.6% of the US population over the age of 40 have reported olfactory dysfunction 
making it one of the most prevalent defects (Battacharya, 2005). There is evidence that individuals 
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with OFC may have higher than normal rates of olfactory deficit.  For example, some Mendelian 
syndromic involve both orofacial clefting and olfactory deficits. 
Kallmann syndrome is a hypogonadotropic hypogonadism condition characterized by 
anosmia (total loss of olfaction) or hyposmia (reduced olfaction), CL/P, unilateral renal agenesis 
and abnormalities of bones in fingers and toes (OMIM: 308700). It can be inherited as X- linked 
recessive when there is a mutation in KAL1 gene, autosomal dominant due to mutations in FGFR1, 
PROKR2, PROK2, CHD7 or FGF8, or autosomal recessive due to mutations in PROKR2 and 
PROK2. 
             Olfactory dysfunction associated with Kallmann syndrome is observed only in KAL2 type 
where there is FGFR1 mutation. It was observed that FGFR1c isoform is important for the 
development of olfactory system (Dode et al., 2007). Cleft palate occurs in 25-30% of the KAL2 
cases (Dode et al., 2003). FGFR1 is important for cell proliferation, migration and differentiation 
thus playing a crucial role in embryological development (Thisse B and Thisse C, 2005). 
It has been shown that anosmin-1 encoded by KAL1 and FGFR1 encoded by KAL2 
colocalized in olfactory bulb of rats during its development. Moreover, it was seen that anosmin-
1 was positive extracellular regulator of FGFR1 signaling suggesting that anosmin-1 plays a 
crucial role in olfactory bulb morphogenesis (Ayari et al., 2007). 
CHARGE syndrome (OMIM# 214800) is another syndrome that shares traits with Kallman 
syndrome (KAL2). Its characteristic features are coloboma, heart anomalies, choanal atresia, 
retardation of growth and/or development, genital and ear anomalies. CL/P occurs in 20-30% of 
the KAL2 and CHARGE syndrome. There is a loss of function mutation in CHD7. It is speculated 
that CHD7 mutation may be involved in the FGFR1 signaling pathway (Hardelin and Dode, 2008). 
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There have been a few studies that support the fact that olfactory deficits are seen in OFC affected 
cases and their UR. 
There have also been several studies documenting various degrees of olfactory deficit in 
non-syndromic cleft cases and their unaffected family members.  These studies suggest that 
children with clefts have nasal vestibule abnormalities or nasal septum deviations secondary to 
surgery may lead to reduced olfaction (or hyposmia). The presence of similar deficits in unaffected 
relatives, however, suggests that there may be a root biological cause. 
Richman et al., (1988): The olfactory response of 35 subjects (20 boys and 15 girls) 
affected with CL/P were studied along with 68 controls (34 boys and 34 girls). Ten common 
household odorants were asked to be identified by the subjects and controls. 50% of the boys 
affected with CP with or without CL had 60% less olfactory scores when compared to 9% of the 
boys without CP, 20% of girls with CP and 15% of girls without CP. The olfactory deficits were 
seen to be higher in the affected boys compared to the control group. This was not the case in the 
females. It was also seen that olfactory function increases with age. 
Grossmann et al., (2005): This study was done to assess the nasal airflow and olfactory 
function in patients affected with CP with or without CL after they underwent surgery. The affected 
group had 15 patients with unilateral cleft palate and lip (UCLP), 2 with only CP (UCLP 
subgroup), 8 with bilateral cleft lip and palate (BCLP subgroup). There were 20 nonaffected 
orthodontic patients in the control group. The nasal airflow was reduced for all CP patients 
(p<0.02). The airflow on the affected side of UCLP group was lower than control (p<0.02). In the 
BCLP group the airflow was reduced and symmetrical in both nostrils. The smell threshold was 
higher in the UCLP group (p<0.01). No significant difference was found in the BCLP group. 
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Significant correlation between the smell threshold and nasal airflow was found in the UCLP group 
(r = -0.33, P = 0.05). 
Even though the above studies indicate that there is some level of olfactory deficits present 
in the OFC groups, they don’t specify the nature of the defects. The question arises if the olfactory 
deficits are innate to the clefting process or if they are secondary to surgical procedures. The 
following studies prove that olfactory deficits are inherent to orofacial clefting. 
Roosenboom et al., (2015): Roosenboom et al had studied the facial characteristics and 
reduced olfaction related to NSCL/P. She concluded that the non-affected first-degree relatives of 
patients with non-syndromic CL/P showed - reduced smell capacity when compared with the 
control group who did not have a family history of Nonsyndromic CL/P. In a follow-up study, 
Roosenboom et al., (2018) administered the sniffin’ sticks olfactory test to 54 NSCL/P patients, 
44 unaffected first-degree relatives of these patients and 35 patients from the control group with a 
negative family history. It was seen that patients with NSCL/P and their unaffected relatives have 
an increased prevalence of hyposmia and anosmia when compared to the control group. It was also 
seen that there was reduced olfactory function among CP patients. The olfactory bulb (OB) volume 
and olfactory sulcus (OS) depths were measured. It was found that NSCL/P patients with hyposmia 
had reduced OB volume. The left OS depth was smaller in NSCL/P patients with hyposmia. 
There was age bias in the study. Even though they compared the different phenotypes of 
clefting in the affected individuals, they could not do the same for the unaffected relatives since 
the sample size was small. 
May et al., (2015): 60 unaffected parents of the patients with OFC were administered the 
UPSIT. Their olfaction scores were compared with 2762 controls. 41.7% of the parents displayed 
olfactory deficits when compared to the 12.6% of controls. 41.7% of the unaffected father 
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displayed olfactory deficits compared to 15.1% of the male controls (p=0.001). Olfactory deficits 
were present in 41.7% of unaffected mothers when compared to 10.4% female controls (p<0.001). 
There was no difference in olfactory deficits between the unaffected fathers and mothers. 
This study concluded that the olfactory deficits were prevalent among the unaffected 
relatives of the individuals affected with clefting. But there was no comparison of the olfactory 
deficits between different subtypes of clefting. Also, the controls used in the study were from the 
UPSIT test manual. 
The above studies suggest that olfaction can be considered as a subclinical feature of 
clefting, but several limitations and biases are present in prior research. In the current study, we 
are trying to overcome the above-mentioned limitations by using a set of carefully collected 
controls, correcting for possible age and sex bias, and comparing olfactory deficits between 
different subtypes of cleft (CL, CLP and CP). 
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2.0 Specific Aims 
Specific Aim1: 
Assess and compare the prevalence of olfactory deficits in affected subjects with CL, CLP 
and CP using the 40 item University of Pennsylvania Smell Identification test. It is hypothesized 
that the individuals affected with CL, CLP and CP will exhibit a higher prevalence of olfactory 
deficits when compared to the control population. 
 
Specific Aim 2: 
Assess and compare the prevalence of olfactory deficits in the unaffected relatives of cases 
affected with CL, CLP and CP using the 40 item University of Pennsylvania Smell Identification 
test. It is hypothesized that the first-degree unaffected relatives of patients affected with CL, CLP 
and CP will exhibit a higher prevalence of olfactory deficits when compared to the control 
population. 
 
Specific Aim 3: 
Assess and compare the prevalence of olfactory deficits in different cleft types and the first-
degree unaffected relatives based on their family type. Based on the association of olfactory 
deficits with syndromic CLP, it is hypothesized that there will be reduced olfactory function in 
relation to palate (i.e., CLP and CP) compared to isolated Cleft lip CLO). 
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3.0 Materials and Methods 
3.1 University of Pennsylvania Smell Identification Test 
The University of Pennsylvania Smell Identification Test (UPSIT) was developed to assess 
quantitative olfactory levels of a patient presenting with olfactory deficits. The test is a self-
administered 40 multiple-choice questionnaire which takes around 10-15 minutes and can be 
scored by non-medical personnel in less than 1 minute. It consists of 4 booklets with 10 questions 
(odorants) per booklet. The odorant in question is placed in a 10-50µm diameter 
microencapsulated crystals which is located on a brown strip (Doty et al., 1984). One has to scratch 
the paper identify the odorant and choose an option. The questions may be framed like “This odor 
smells most like a (a) Chocolate (b) Banana (c) Onion or (d) Fruit punch”. This test is a forced 
choice method since one has to choose an answer even if an odor cannot be perceived. The rate of 
reliability is high r=0.94 (Doty et al., 1989a). 
The UPSIT scoring manual is based on the olfaction data from 4000 control individuals. 
Individuals who take the UPSIT are scored based on these norms. Since the scoring in the manual 
is adjusted for age and sex, it also indicates how a tested individual has performed when compared 
to his age group and gender (Doty, 2008). 
Ease of administration, reliability, less time that is required to complete the test, durability 
of the test makes it one of the most sought-after tests. Despite its advantages there is also a cultural 
bias. It is said that the test is based mostly on American culture and might not be applicable to 
other cultures. Also, the test only detects smell deficits above the threshold level. It does not test 
for Odor detection threshold or odor identification threshold. They can only identify the different 
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odors. Odor detection threshold can be defined as the lowest concentration of an odorant which 
could be perceived by humans. Odor identification threshold is the concentration at which 50% of 
the human population will be able to discriminate between odors.  
3.2 Data Collection 
3.2.1  Subject Recruitment 
Individuals with OFC, their unaffected relatives (UR) and unaffected controls were 
recruited from Pittsburgh, Lancaster, Puerto Rico, and Colombia as part of the larger Pittsburgh 
Orofacial Clefting study. OFC affected individuals included those affected with only unilateral or 
bilateral cleft lip, cleft lip without or without cleft palate and only cleft palate.          
3.2.2  Inclusion and Exclusion criteria 
Subjects between 10 and 59 years of age, who were white, non-Hispanic were included. 
USPIT scores for this age range have been reported to be the most reliable (Doty et al., 1984a). 
Other racial and ethnic groups were not included in the current study since our samples are too 
small in these groups and there are known ethnic differences in olfactory ability (Hoffman et al., 
2010) and potential testing biases (Doty et al., 1985a). 
The effect of smoking on olfactory function is dose related. In a study where UPSIT was 
administered to 638 people with a history of smoking, it was seen that long-term smoking had a 
reversible effect on olfaction (Frye, Doty et al., 1990). In our study 3 out of 32 cases, 56 out of 
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100 UR and 199 out of 447 controls were smokers. Excluding them will result in small sample 
size (Table 1). Hence, they were included in the study. Smoking bias is another limitation for our 
study. 
 
Table 1 Group Demographic Composition  
PARAMETER CASES UNAFFECTED 
RELATIVES 
CONTROLS 
N   32     122      447 
AVERAGE AGE 20.0 yrs.    31.9 yrs.     32.4 yrs. 
SEX 17M/15F   48M/74F     165M/282F 
SMOKERS     3        56      199 
NON-SMOKERS   29        66      248     
 
Allergic rhinitis or nasal sinus disease may cause nasal congestion. It has been suggested 
that the destruction of the nasal mucosa due to inflammation or other obstructions may cause 
significant olfactory deficit (Cowart et al., 1993). Head injury is one of the important reasons for 
olfactory deficit. Approximately 5-20% of the patients presenting with olfactory deficit have a 
history of trauma. The shearing of olfactory nerve fibers and their connections to the olfactory 
bulb during the accident may cause olfactory deficits (Muller and Hummel 2009). The limbic 
system is responsible for our emotional behavior. The olfactory bulb has projections into the limbic 
system structures such as amygdala, hippocampus, insula, anterior cingulate cortex and 
orbitofrontal cortex. This shared network may be responsible for olfactory deficits seen in patients 
suffering from depression (Kohli et al., 2016). Citalopram, clomipramine and Rolipram are all 
antidepressants that has the same target receptor- ADRA1A (adrenoceptor α1A). Blocking this 
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receptor has shown to inhibit the GABAergic inhibition of mitral cells present in the olfactory bulb 
(Lötch et al., 2015). Hence subjects were excluded based on nasal congestion, history of loss of 
smell due to trauma, depression and anti-depressants. 
3.2.3  Study sample 
After applying inclusion/exclusion criteria, a total of 32 individuals with OFC, 100 
unaffected relatives (UR) and 422 controls were included. Among the 32 cases 8 were affected 
with cleft lip (CL), 15 were affected with cleft lip with palate (CLP) and 9 were affected with only 
cleft palate. 
Among the 100 unaffected relatives 14 belong to the cleft lip family type, 66 belong to 
cleft lip and palate family type and 20 belong to cleft palate family type. 
3.3 Data Analysis 
The statistical analysis for this study was done using GraphPad PRISM version8 and R. 
Two types of comparisons were made between the cases and the controls, and (UR) and controls. 
The first analysis approach divided individuals into clinically-defined deficit or no deficit 
categories based the UPSIT score. The second approach involved comparisons based on the raw 
UPSIT scores. 
Based on the UPSIT norms the olfactory deficits had been scored as Normosmia, mild 
microsmia, moderate microsmia, severe microsmia and total anosmia. For comparison purposes 
normosia is considered as the “No deficit” group. Mild, moderate, severe microsmia and total 
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anosmia as a whole is considered as “Smell Deficits” group. There was no age or sex bias when 
comparisons were made based on “Smell deficits: and “No deficits”. This is because when the 
subjects are scored and assigned an olfactory status, this is based on UPSIT norms which have 
already been adjusted for age and sex. The Chi-Square test was used to compare categories (deficit 
vs no deficit) between the cases/UR and controls. The fisher exact test was used to compare smaller 
sample size.  
For the first and the second part of the specific aim the following comparisons were made 
(figure 8). 
 
Figure 8 Comparisons for specific aim 1 and 2 
For the third part of the specific aim the following comparisons were made (figure 9). 
 
 
Comparisons
Cases vs Controls
Smell deficits
UPSIT scores
Unaffected 
relatives vs 
Controls
Smell Deficits
UPSIT scores
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Figure 9 Comparisons for specific aim 3 
For the raw UPSIT score comparison, age and sex effects had to be taken into account 
between these can have an effect on olfactory function (Doty et al., 1984a; Doty et al., 1985a). To 
solve for the potential age and sex bias when comparing the cases and UR to controls based on 
UPSIT scores, each case and UR were matched to two controls by age and sex. For example, if 
there was a male who was 10 years old in the case cohort, he was matched to two males in the 
control group who are of the same age. The UPSIT score distribution deviated from normality 
based on the Shapiro Wilk test. Thus, the non-parametric Mann Whitney U test was used for all 
UPSIT score between comparisons.  
All statistical tests were considered one-sided due to the direction of effect indicated in the 
hypotheses.  All results were considered statistically significant at p ≤ 0.05.   
 
Comparison
CL vs Controls
CLP vs Controls
CP vs Controls
Smell Deficits
UPSIT scores
CASES and UR 
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4.0 Results 
Olfactory dysfunction is categorized into 5 clinical categories based on the UPSIT scores- 
Normosia, Mild microsmia, Moderate microsmia, severe microsmia and total anosmia. Table 2 
describes the distribution of olfactory deficits between the cases, UR and controls. It could be 
observed that most of the subjects are in the mild microsmia and normosia category. 25 of the 32 
cases fall in the normosia and mild microsmia category. 108 of the 122 UR falls in the normosia 
and mild microsmia category. 419 of the 447 controls fall in the normosia and mild microsmia 
category. 
Table 2 Distribution of smell deficits in cases, UR and controls 
 Normosia Mild 
microsmia 
Moderate 
microsmia 
Severe 
microsmia 
Total 
anosmia 
Cases 15  10  4  2  1  
UR 78  30  10  2  2  
Controls 333  86  22  3  3  
 
                It was not possible to compare between different levels of olfactory deficits such as 
normosia, mild microsmia, moderate microsmia and severe microsmia since the sample size of 
each of these groups was too small. Hence normosia was considered the “no deficit” group and 
the other categories of olfactory deficit were considered as one single “smell deficit” group (table 
3). It could be observed from table 3 that 17 of the 32 (more than 50%) cases have smell deficits. 
44 of the 122 UR (37%) have smell deficits compared to 114 of the 447 controls (24.4%). 
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Table 3 Frequency of smell deficits and no deficits in the Cases, UR and Controls 
 Cases  
N=32 
Unaffected Relatives 
N=122 
Controls 
N=447 
Smell Deficits 17 (53%) 44 (37%) 114 (24.4%) 
No deficits 15 (47%) 78 (63%) 333 (75.6%) 
 
              The distribution of raw UPSIT scores in cases, UR and Controls is presented in figure 10. 
The average UPSIT score is low in cases compared to UR and Controls. Similarly, the UPSIT 
average of UR is lower compared to controls. 
                               
Figure 10 Distribution of UPSIT scores in Cases, UR and Controls 
The distribution of UPSIT scores for the cleft type of cases and family type of UR and 
controls is described in figure 11. It could be seen that the average UPSIT score for CLP cleft type 
of cases is lower compared to CL and CP type. The UPSIT average of CLP family type is lower 
compared to CL and CP family type. 
X axis: Cases, UR 
and Controls 
Y axis: UPSIT 
scores 
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Figure 11 Distribution of UPSIT scores based on each cleft type 
The distribution of UPSIT scores in Cases, UR and controls between smokers and non-
smokers are described in figures 12, 13 and 14. In figure 12 it could be observed that 3 of the cases 
were smokers and their UPSIT scores were between 37 and 39. 
 
Figure 12 Distribution of UPSIT scores in cases between smokers and non-smokers 
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In figure 13 it could be observed that 56 of the 122 UR were smokers. Their UPSIT scores 
were between 26 and 40. 
 
Figure 13 Distribution of UPSIT scores in UR between Smokers and non-smokers 
In figure 14 it could be observed that 199 of the 447 controls were smokers. Their UPSIT 
scores were between 16 and 40. 
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Figure 14 Distribution of UPSIT scores in Controls between smokers and non-smokers 
4.1 Results for specific aim 1 
 
For specific aim 1, olfactory deficits in cases were compared to controls. The comparisons 
were based on “smell deficit” categories and “UPSIT scores”. It could be seen from Table 4 that 
there is a significant difference when comparing cases vs controls based on smell deficits. 
Although mean UPSIT scores were higher in age and sex matched controls (as predicted), the 
difference was not statistically significant (Table 5). Figure 15 shows the distribution of scores 
between cases and controls. 
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Table 4 All Cases vs Controls based on smell deficits 
 Cases n=32 Controls n=64 
Smell deficit 17 114 
No deficit 15 333 
p-value 0.00004 
 
Table 5 All Cases vs Controls based on UPSIT scores 
 Case n=32 Controls n=64 
UPSIT Average 32.7 33.9 
p-value 0.37 
                                             
 
Figure 15 Graph describing the UPSIT scores for all cases vs controls 
 
X axis: cases and  
          Controls 
Y axis: UPSIT scores 
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4.2 Results for Specific Aim 2 
     
For specific aim 2, olfactory deficits in UR were compared to controls. The comparisons 
were based on “smell deficit” categories and “UPSIT scores”. It could be seen from Table 6 and 7 
that UR showed both significantly higher rates of olfactory deficit and lower mean UPSIT scores 
compared with controls. Figure 16 shows the distribution of scores between UR and controls. 
 
Table 6 All UR vs Controls based on smell deficits 
 Unaffected relatives Controls 
Smell deficit  44 114 
No deficit 78 333 
p-value 0.06 
 
 
Table 7 All UR vs Controls based on UPSIT scores 
 Unaffected relatives Controls 
UPSIT average 34.06 35.22 
p-value 0.0035 
 
 30 
             
Figure 16 Graph describing the UPSIT score for All UR vs Controls 
 
 
4.3 Specific Aim 3 
For the first part of specific aim 3, the affected cases were divided by cleft type and each compared 
with controls. Based on smell deficit categories, all three cleft types showed significantly higher 
rates of deficit compared with controls (Table 8).  Although UPSIT the mean scores were lower in 
CLP and CP cases vs age and sex matched controls, these results were not statistically significant 
(Table 9 and Figures 17 and 18). In contrast, in CL cases the mean score was higher than controls, 
but this was also not significant (Table 9 and Figure 19). 
 
  
 
X axis: UR and  
Control 
Y axis: UPSIT  
Scores 
 31 
Table 8 Cleft phenotypes of cases vs controls based on smell deficits 
 CL CLP CP Controls 
Smell Deficits 4 9 4 114 
No Deficits 4 6 5 333 
P value 0.0002 4.41E-07 0.002 
  
 
Table 9 Cleft phenotypes of cases vs controls based on UPSIT scores 
 CL Controls CLP Controls CP Controls 
UPSIT 
average 
33.75 33.25 31.2 33.8 34.22 34.78 
p-value                0.32                0.28                 0.43 
             
Figure 17 Graph describing UPSIT score of CL vs Control 
 
 
X axis: CL cases 
And Control 
Y axis: UPSIT  
Scores 
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Figure 18 Graph describing UPSIT score of CLP vs controls 
 
 
Figure 19 Graph describing UPSIT score of CP vs Controls 
 
For the second part of specific aim 3, URs were divided by cleft family type and compared 
with controls. Based on smell deficit categories, URs from CL/P family types showed significantly 
X axis: CLP cases 
And Control 
Y axis: UPSIT  
Scores 
X axis: CP cases 
       And Control 
Y axis: UPSIT  
Scores 
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higher rates of deficit compared with controls (Table 10).  URs from CL and CP family types also 
showed an increased deficit rate, but these differences were not statistically significant.  All three 
UR groups showed lower mean UPSIT scores compared with age and sex matched controls, but 
this difference was only significant in CL/P and CP cases (Table 11 and Figures 20-22). 
 
Table 10 Cleft family type of uR vs Controls based on smell deficits 
 CL UR CL/P UR CP UR Controls 
Smell Deficits 5 26 6 114 
No Deficits 9 41 14 333 
p-value 0.06 0.03 0.26 
 
 
 
 
Table 11 Cleft family type of UR vs Controls based on UPSIT scores 
 CL UR Controls CL/P UR Controls CP UR Controls 
UPSIT 
average 
34.6 35.1 33.57 34.99 35.25 36.1 
p-value                  0.76                  0.03                 0.048 
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Figure 20 Graph describing UPSIT score of CL relative vs Control 
 
 
Figure 21 Graph describing UPSIT score of CLP relative vs Controls 
X axis: CL UR 
And Control 
Y axis: UPSIT  
Scores 
X axis: CLP UR 
And Control 
Y axis: UPSIT  
Scores 
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Figure 22 Graph describing UPSIT score of CP relative vs Control 
X axis: CP UR 
And Control 
Y axis: UPSIT  
Scores 
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5.0 Discussion 
It has been observed previously that individuals affected with OFC show decreased 
olfactory ability compared with the general population (Richman et al., 1988; Grossman et al., 
2005; May et al., 2015; Roosenboom et al., 2015; 2017). Our results lend strong support to these 
earlier reports. 53.1% of our OFC cases had some evidence of a smell deficit compared to 24.4% 
of controls. For reports that focused only on affected cases (Richman et al., 1988; Grossman et al., 
2005) there was no way of distinguishing whether the high rate of olfactory deficits was simply a 
secondary byproduct of the surgical repair or was an intrinsic part of the OFC phenotype. Looking 
at the rate of olfactory deficit in unaffected family members is one way to approach this problem, 
since these individuals have the genetic risk factors for OFC but have not had a surgical repair. 
Several prior reports have also shown reduced olfaction in relatives (May et al., 2015; 
Roosenboom et al., 2015; Roosenboom et al., 2017). Our results support this claim, with 36% of 
our URs showing olfactory deficits compared to 24.4% of controls. The prevalence of olfactory 
deficits in URs suggests that olfactory deficits may be inherent to OFC may be considered part of 
the OFC phenotypic spectrum. It is notable that these replications were observed despite 
differences in the olfactory testing protocols among studies. 
One advance of the current study is that we were able to test and compare olfactory ability 
across different cleft subtypes. In an earlier report, Roosenboom et al., (2017) concluded that there 
were no significant differences in olfactory ability between the cleft subtypes. While our study 
also found that CL, CLP and CP cases all showed reduced olfactory ability compared to controls, 
we were able to extend some of these findings to URs. When looking at smell deficit as a 
categorical trait, URs from all three family types (CL, CL/P, and CP) all showed evidence of 
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reduced olfactory ability, but this difference was only significant in URs from CL/P families. The 
CL/P group was also the largest of the three, so this may be a sample size effect. When the raw 
UPSI scores were compared, again all three UR groups showed evidence of worse olfactory 
performance, but the difference was only significant in URs from CL/P and CP families.  This 
study is the first to compare the difference in olfactory deficits among the UR family types of OFC. 
The results overall provide only weak evidence that clefts involving the secondary palate (CL/P 
and CP) show greater olfactory deficits compared to clefts involving only the primary palate.  In 
fact, the rate of smell deficit observed in both cases and URs was actually higher in CL compared 
to CP.  To confirm this, larger sample sizes for each subtype would be needed. 
Olfactory dysfunction may be due to pathology in the normal anatomy such as damage to 
the olfactory filaments due to a trauma. Viruses may cause an inflammation that may result in 
olfactory dysfunction (Hummel et al., 2012). Kallman syndrome and CHARGE syndrome 
suggests that there might be an involvement of genetic components. A 16-year-old female who 
presented with Kallman syndrome had anosmia and CLP. The R609X nonsense mutation was 
found in the FGFR1 gene of this female. Her father who presented with isolated CLP also had the 
same R609X mutation (Riley et al., 2007). Zenaty et al., (2006) had reported three cases with 
Kallmann syndrome. Of the three cases two had unusual phenotype feature associated with it such 
as ear anomalies. Kallmann syndrome features such as CP, anosmia and dental anomalies were 
present. They identified de novo mutations Cys178Ser and Arg622Gly in two cases and the third 
case inherited Arg622Gln mutation with intrafamilial variable phenotype. These cases suggest the 
non- penetrance effect that makes studying isolated clefts difficult. FGFR1 has a role in clefting, 
16 mutations have been identified in the FGFR1 coding region of patients with Kallmann 
syndrome (Dode et al.,2003; Dode et al., 2007; Zenaty et al., 2006; Pitteloud et al., 2006; Pitteloud 
 38 
et al., 2006; Trarbach et al., 2006). Testing of FGFR1 mutations in families with olfactory deficits 
may identify genetic subtypes of clefting. It was seen that in a group of children affected with 
22q11 deletion syndrome, olfactory dysfunction is a result of surgery and insertion of nasogastric 
tubes (Sobin et al, 2009). The prevalence of olfactory deficits in the UR in our study and previous 
studies suggest that olfactory dysfunction might not be a consequence of external physical factors 
such as surgical repair. Grossmann et al., (2005) reported that there was a decreased nasal airflow 
in UCLP and BCLP subjects. But there was no relationship between cleft type, nasal airflow and 
smell threshold. If changes in anatomy is responsible for changes in nasal airflow that may affect 
odor discrimination ability, then one can expect that similar anatomical difference in family 
member may cause olfactory dysfunction. 
Another possibility is that the root cause of the deficit is in the parts of the brain where 
smell is processed.  One of the limitations for our study was we were not able to study function in 
relation to the anatomy of olfactory system components in the brain. Roosenboom et al., (2017) 
showed that there was reduced olfactory sulcus depth in URs with smell deficits. Her previous 
study also showed that there was a reduced upper nasal region in URs (Roosenboom et al., 2015). 
During facial development the olfactory placode, central upper lip and primary palate share the 
same facial prominence. One could expect that olfactory dysfunction and CL/P may share the same 
pathogenesis. In the future, it would be informative to study olfactory bulb and other olfaction-
related brain centers in these URs and cases compared to controls.  
The study of olfaction is relevant to public health. Impaired olfactory ability has been 
associated with a decreased quality of life (Frasnelli and Hummel, 2005). One reason for this is 
that olfaction is an important factor in a person’s emotional and social behavior (Sarafoleanu et al 
2009; Seo et al., 2013). Sometimes reduced olfaction can also be life threatening when one is not 
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able to detect a gas leak (Miwa et al., 2001) or spoiled food (Stevenson, 2010). Thus, reduced 
olfaction should be considered seriously as it can negatively impact one’s life. Assessing olfactory 
deficits in the OFC population may be an important factor for improving quality of life and could 
lead to earlier interventions. Identifying a genetic basis of the olfactory deficit in this population 
may provide new insights into the etiology of the condition and enable screening of individuals 
likely to exhibit olfactory problems.   
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